Amivantamab
CAS 1835520-85-8Biologic
Overview
Amivantamab is a monoclonal antibody designed to target EGFR and MET receptors, used in the treatment of non-small cell lung cancer with EGFR exon 20 insertion mutations. It works by inhibiting tumor growth and promoting immune cell-mediated cytotoxicity.
Therapeutic areas
Oncology
Verified Supplier Partner
Do you supply Amivantamab? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.